Cannabidiol inhibits both human KV7.1 and KV7.1/KCNE1 channels through distinct sites
Why the study?
Little was known about the binding sites through which cannabidiol mediates inhibitory effects on KV7.1 and KV7.1/KCNE1, limiting insight toward developing selective KV7 modulators.
Population
Human KV7.1 and KV7.1/KCNE1 channels expressed in Xenopus laevis oocytes
Design
Preclinical computational and electrophysiological study
Key result
Cannabidiol inhibits human KV7.1 and KV7.1/KCNE1 potassium channels by binding to distinct sites, specifically the S5-S6 site in KV7.1 and the S6-S5'-E1 site in KV7.1/KCNE1.
Authors
Loading...
CBD use warrants cardiac caution in vulnerable patients; extends insights into distinct binding sites to guide safer subtype-selective KV7 modulators.
Elucidates the distinct structural binding sites of cannabidiol on human KV7.1 and KV7.1/KCNE1 channels, providing critical molecular insights to guide the rational design of subtype-selective KV7 modulators lacking proarrhythmic cardiac effects.
Kusay et al. (2026) studied this question. Cannabidiol (CBD) vs. Wild-type channels was evaluated on Change in maximum conductance (ΔGMax) and voltage-dependence of activation (ΔV50). Cannabidiol inhibits human KV7.1 and KV7.1/KCNE1 potassium channels by binding to distinct sites, specifically the S5-S6 site in KV7.1 and the S6-S5'-E1 site in KV7.1/KCNE1.